New perspective therapy of breast cancer based on selective dopamine receptor D2 agonist and antagonist effects on MCF-7 cell line.

Pornour, Majid

New perspective therapy of breast cancer based on selective dopamine receptor D2 agonist and antagonist effects on MCF-7 cell line. [electronic resource] - Recent patents on anti-cancer drug discovery 2015 - 214-23 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

2212-3970

10.2174/1574892810666150416111831 doi


Antineoplastic Agents--administration & dosage
Apoptosis--drug effects
Breast Neoplasms--drug therapy
Bromocriptine--administration & dosage
Cell Survival--drug effects
Dopamine Agonists--administration & dosage
Dopamine D2 Receptor Antagonists--administration & dosage
Dose-Response Relationship, Drug
Female
Gene Expression Regulation, Neoplastic
Humans
MCF-7 Cells
Patents as Topic
Proliferating Cell Nuclear Antigen--genetics
Receptors, Dopamine D2--agonists
Remoxipride--administration & dosage